-
1
Genetically engineered bacteria can deliver anti-inflammatory therapy.
-
2
IL-10 enhances corneal epithelial repair.
-
3
Traditional treatments are limited by rapid clearance.
-
4
Corynebacterium mastitidis used for colonization.
-
5
Potential for various ocular surface disorders.
-
6
Approach remains preclinical but shows promise for a new treatment class.
Original Source(s)
Related Content
Introducing: Moorfields and UCL Centre for Eye Health
New London eye health centre named ahead of 2027 summer opening
April 17, 2026
-
2 min
Unraveling Cataract’s Molecular Origins
UC Irvine research sheds new light on age-related cataract formation
April 17, 2026
-
3 min
Radical Transparency: The Future of Ophthalmic Practice
As patient expectations and legal scrutiny rise, ophthalmology must strive to measure and document every step of care
by Mfazo Hove
April 16, 2026
-
6 min
